share_log

Morgan Stanley Maintains Overweight on United Therapeutics, Lowers Price Target to $316

Benzinga ·  Apr 10, 2023 10:27

Morgan Stanley analyst Terence Flynn maintains United Therapeutics (NASDAQ:UTHR) with a Overweight and lowers the price target from $320 to $316.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment